Detalhe da pesquisa
1.
Minimal residual disease-driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL.
Blood
; 140(22): 2348-2357, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35921541
2.
Disrupting pro-survival and inflammatory pathways with dimethyl fumarate sensitizes chronic lymphocytic leukemia to cell death.
Cell Death Dis
; 15(3): 224, 2024 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38494482
3.
IκBε deficiency accelerates disease development in chronic lymphocytic leukemia.
Leukemia
; 38(6): 1287-1298, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38575671